Buprenorphine

NDC 69238-1203 · Amneal Pharmaceuticals NY LLC

Generic nameBuprenorphine

Dosage formPATCH, EXTENDED RELEASE

RouteTRANSDERMAL

Active ingredient(s)BUPRENORPHINE

Strength10 ug/h

Pharmacologic classPartial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]

DEA scheduleCIII

Marketing categoryANDA

Packages

69238-1203-2 — 4 POUCH in 1 CARTON (69238-1203-2) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH

FDA lists these products with the same active ingredient.

58284-208 — BUPRENORPHINE, 58284-216 — BUPRENORPHINE, 58284-224 — BUPRENORPHINE, 58284-228 — BUPRENORPHINE, 58284-232 — BUPRENORPHINE, 58284-264 — BUPRENORPHINE, 58284-296 — BUPRENORPHINE, 59011-750 — buprenorphine, 59011-751 — buprenorphine, 59011-752 — buprenorphine, 59011-757 — buprenorphine, 59011-758 — buprenorphine, 62175-452 — Buprenorphine and Naloxone, 62175-458 — Buprenorphine and Naloxone, 69238-1202 — Buprenorphine, 69238-1204 — Buprenorphine, 69238-1205 — Buprenorphine, 69238-1505 — Buprenorphine, 71335-1296 — Buprenorphine and Naloxone, 71335-1378 — Buprenorphine and Naloxone, +27 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.